Alterity Therapeutics to Present at Bell Conference
Ticker: PRNAF · Form: 6-K · Filed: Nov 12, 2025 · CIK: 1131343
| Field | Detail |
|---|---|
| Company | Alterity Therapeutics Ltd (PRNAF) |
| Form Type | 6-K |
| Filed Date | Nov 12, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: conference-presentation, filing-update, registration-statement
Related Tickers: ALT
TL;DR
ALT to present at Bell Conf Nov 12, filing incorporated into S-8/F-3 regs.
AI Summary
Alterity Therapeutics Ltd. announced on November 12, 2025, that it will present at the Bell Conference. This filing incorporates by reference the 6-K report into several of Alterity's existing Registration Statements on Form S-8 and Form F-3.
Why It Matters
This presentation could provide updates on Alterity's drug development pipeline, potentially impacting investor sentiment and stock valuation.
Risk Assessment
Risk Level: low — The filing is a routine report of a foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- Alterity Therapeutics Ltd. (company) — Registrant
- Bell Conference (event) — Presentation topic
- November 12, 2025 (date) — Date of report and presentation
- Form S-8 (document) — Incorporated by reference
- Form F-3 (document) — Incorporated by reference
FAQ
What is the specific topic of Alterity Therapeutics' presentation at the Bell Conference?
The filing does not specify the exact topic of the presentation, only that Alterity Therapeutics will present at the Bell Conference.
Which Registration Statements is this 6-K filing being incorporated into?
This 6-K filing is being incorporated by reference into Alterity's Registration Statements on Form S-8 (Files No. 333-251073, 333-248980 and 333-228671) and Form F-3 (Files No. 333-274816, 333-251647, 333-231417 and 333-250076).
What is the primary purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer, announcing Alterity's participation in the Bell Conference and incorporating the report into existing registration statements.
When was this Form 6-K filed?
This Form 6-K was filed on November 12, 2025.
Does Alterity Therapeutics file annual reports under Form 20-F or Form 40-F?
Alterity Therapeutics indicates it files annual reports under Form 20-F.
Filing Stats: 194 words · 1 min read · ~1 pages · Grade level 12.1 · Accepted 2025-11-12 08:08:15
Filing Documents
- ea0265246-6k_alterity.htm (6-K) — 13KB
- ea026524601ex99-1_alterity.htm (EX-99.1) — 13KB
- ex99-1_001.jpg (GRAPHIC) — 4KB
- 0001213900-25-108761.txt ( ) — 34KB
From the Filing
OF FOREIGN PRIVATE ISSUER SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-163 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 12, 2025 Alterity Therapeutics Limited (Name of Registrant) Level 14, 350 Collins Street, Melbourne, Victoria 3000 Australia (Address of Principal Executive Office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F This Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-251073 , 333-248980 and 333-228671 ) and our Registration Statements on Form F-3 (Files No. 333-274816 , 333-251647 , 333-231417 and 333-250076 ) ALTERITY THERAPEUTICS LIMITED (a development stage enterprise) The following exhibits are submitted: 99.1 Alterity to Present at the Bell Potter Healthcare Conference 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Alterity Therapeutics Limited By: /s/ Geoffrey P. Kempler Geoffrey P. Kempler Chairman Date: November 12, 2025 2